**Core Concept**
Pancuronium is a non-depolarizing neuromuscular blocking agent, used to facilitate endotracheal intubation and provide skeletal muscle relaxation during surgery. Its mechanism of action involves competitively inhibiting acetylcholine receptors at the neuromuscular junction.

**Why the Correct Answer is Right**
The intubation dose of pancuronium is typically 0.1-0.2 mg/kg, administered intravenously. This dose is sufficient to produce adequate muscle relaxation and facilitate endotracheal intubation. Pancuronium's pharmacodynamics are characterized by a rapid onset of action, with peak effects occurring within 2-5 minutes.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because the intubation dose of pancuronium is not typically 0.5 mg/kg, which would be excessive and potentially lead to prolonged paralysis.
**Option B:** This option is incorrect because the intubation dose of pancuronium is not typically 0.05 mg/kg, which would be insufficient to produce adequate muscle relaxation.
**Option C:** This option is incorrect because the intubation dose of pancuronium is not typically 0.3 mg/kg, which is close but still not the most commonly recommended dose.

**Clinical Pearl / High-Yield Fact**
It's essential to note that the dose of pancuronium may need to be adjusted in patients with renal or hepatic impairment, as the drug is primarily excreted by the kidneys and metabolized by the liver.

**Correct Answer:** C. 0.1-0.2 mg/kg.